Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards
Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards
Considering the rapid improvement of cancer drugs' efficacy and the discovery of new molecular targets, the formulation of therapeutical indications based on the multidisciplinary approach of MTB is becoming increasingly important for attributing the correct salience to the targets identified in a single patient. Nevertheless, one of the biggest stumbling …